Ticlopidine
- TRADE NAMES: Anagregal; Panaldine; Ticlid (Roche); Ticlidil; Ticlodix; Ticlodone; Tiklid; Tiklyd
- INDICATIONS: To reduce risk of thrombotic stroke
- CLASS: Antiplatelet; thienopyridine, CYP1A2 inhibitor
- HALF-LIFE: 24 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alteplase, Clobazam, Dabigatran, Fondaparinux, Lepirudin, Oxtriphylline, Phenytoin, Tinzaparin
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 08/02/2021
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
